TrialCancer2012

Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971: a report from the Children's Oncology Group.

April D Sorrell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.